Stockholders' Equity (Details) $ / shares in Units, $ in Millions	1 Months Ended		12 Months Ended
	Jun. 30, 2021 USD ($) $ / shares shares	Dec. 31, 2015 $ / shares shares	Dec. 31, 2021 $ / shares shares	Dec. 31, 2020 $ / shares shares	Dec. 31, 2019 $ / shares shares	Dec. 31, 2018 shares	Dec. 31, 2017 $ / shares shares	Oct. 30, 2020 $ / shares shares
Stockholders' Equity (Details) [Line Items]
Common stock, shares authorized			500,000,000	500,000,000
Preference stock, shares authorized			5,000,000	5,000,000
Common stock, par value (in Dollars per share) | $ / shares			$ 0.0001	$ 0.0001
Preference stock, par value (in Dollars per share) | $ / shares			$ 0.0001	$ 0.0001
Common stock, shares issued			99,274,594	74,898,380
Common stock, shares outstanding			99,274,594	74,898,380
Number of vote			1
Aggregate net proceeds (in Dollars) | $	$ 51.5
Underwriting discounts and commissions (in Dollars) | $	3.2
Net offering expenses (in Dollars) | $	$ 0.5
Description of credit facility	As discussed in Note 12, Debt, a portion of the proceeds were used to repay (i) $10.8 million of the term loan facility, including $10.0 million of principal, $0.5 million of payoff fee, and $0.3 million of related prepayment premiums and accrued interest, and (ii) $13.7 million to liquidate the Subordinated Note.
Exchange ratio per share (in Dollars per share) | $ / shares			$ 0.4047
Merger transaction description.			As part of the Merger Transaction the following events occurred impacting Legacy SOC Telemed common stock:    ● Treasury stock was retired.     ● Series H preferred stock was partially redeemed in exchange for Class A common stock resulting in 10,600,347 shares of Class A common stock being issued to the previous Series H preferred stockholders.     ● All vested stock options under the Legacy SOC Telemed 2014 Equity Incentive Plan were exercised into Class A common stock resulting in 2,643,694 shares of Class A common stock.     ● All outstanding warrants to purchase shares of Legacy SOC Telemed common stock were exercised into Class A common stock resulting in 1,169,452 shares of Class A common stock.     ● The Company issued 11,468,485 shares of Class A common stock and the Sponsor Earnout Shares to the former stockholders of HCMC for $ 64.6 million in cash.     ● The Company issued 16,800,000 Class A common shares for $168,000,000 through the PIPE, as discussed in Note 4.  Apart from the above Merger Transaction related activity, common warrants of Legacy SOC Telemed were exercised during 2020 resulting in 40,795 new shares of Legacy SOC Telemed common stock shares being issued prior to the Merger Transaction.
Common stock, shares outstanding			12,849,992
Common stock at an exercise price of per share (in Dollars per share) | $ / shares		$ 2.87
2015 Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Warrants purchase share		1
2017 and 2018 Series I Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, shares issued						124,105	62,057
Warrants converted into shares per share (in Dollars per share) | $ / shares							$ 0.02
Warrants, description						the Company issued an additional 124,105 Series I common warrants under the same terms, exercisable through April and August 2023.	The warrants were exercisable from the date of issuance through November and December 2022.
2019 and 2020 Series J Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, shares issued				120,150	108,460
Warrants purchase share					11
Warrants converted into shares per share (in Dollars per share) | $ / shares					$ 0.02
Warrants, description				the Company issued an additional 120,150 Series J common warrants under the same terms, exercisable from the date of issuance through June 2025.
2020 Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, shares issued								12,849,992
Common stock at an exercise price of per share (in Dollars per share) | $ / shares								$ 11.5
Warrants			12,849,992	12,849,992
Warrant [Member] | 2020 Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Warrants			12,499,992
Private Placement [Member]
Stockholders' Equity (Details) [Line Items]
Warrants								350,000
Private Placement [Member] | 2020 Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Warrants			350,000
Common Class A [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, shares authorized			500,000,000
Common stock, par value (in Dollars per share) | $ / shares			$ 0.0001
Common stock, shares issued			99,274,594
Common stock, shares outstanding				74,898,380
Class A common stock at an offering price	9,200,000		10,600,347
Class A common stock at an offering price, per share (in Dollars per share) | $ / shares	$ 6
Purchase of additional shares	1,200,000
Exchange ratio per share (in Dollars per share) | $ / shares								$ 0.4047
Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Preference stock, par value (in Dollars per share) | $ / shares			$ 0.0001
Series H Warrants [Member] | 2015 Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Warrants purchase share		123,432
Series G Warrants [Member] | 2015 Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Warrants purchase share		851,718
Common Warrants [Member] | 2017 and 2018 Series I Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Warrants purchase share							9